Citi lowered the firm’s price target on Clover Health to $1 from $1.50 and keeps a Neutral rating on the shares. The analyst updated the company’s model post the Q3 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLOV:
- Clover Health price target lowered to $1 from $1.50 at Citi
- Clover Health price target lowered to $2 from $3 at Canaccord
- Clover Health reports Q3 revenue $482.07M, consensus $494.6M
- Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance
- Clover Health options imply 11.6% move in share price post-earnings
